Gaslightwala Abizer bought AKTX
March 6, 2025 · Form 4 insider transaction
Gaslightwala Abizer bought 133,928 shares of Akari Therapeutics, Plc at $1.12 per share, a transaction worth $150.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.; On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant.